[1]
“SAFETY, EFFICACY AND TOLERABILITY OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS (ARNI) IN PATIENTS WITH CHRONIC HEART FAILURE”, RMSR, vol. 3, no. 1, pp. 522–531, Jan. 2025, Accessed: Jan. 15, 2025. [Online]. Available: http://thermsr.com/index.php/Journal/article/view/403